Cite
MLA Citation
Iris Kistner et al.. “Benefits and Risks of Aliskiren Treatment in Patients With Type 2 Diabetes: Analyses of the 3A Registry.” Journal of clinical hypertension, vol. 18, no. 10, 2016, pp. 1045–1053. http://access.bl.uk/ark:/81055/vdc_100038571645.0x00000c